GGrantIndex
← Leaderboards

Jerilyn A Logemann

Northwestern University

$11,669,878
Attributed
$11,669,878
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $941.4K · FY200513
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$13,148,697 · 10

By mechanism

R01$5,703,909 · 2
U01$4,270,532 · 1
P01$2,241,095 · 4
R21$504,531 · 2
P50$428,630 · 1

Top collaborators

No co-investigators on record.

Most similar at Northwestern University

Same institution · by research overlap

Others in their field

Top investigators on “Human Therapy Evaluation

Research focus

Human Therapy EvaluationHuman SubjectSwallowingClinical ResearchLongitudinal Human StudyHead /Neck NeoplasmOutcomes ResearchParkinson'S DiseaseCancer Rehabilitation /CarePneumoniaBehavioral /Social Science Research TagDisease /Disorder Proneness /RiskBiomechanicsPatient Oriented ResearchPsychomotor FunctionNeoplasm /Cancer Radiation TherapyOral Pharyngeal DisorderFluoroscopyDysphagiaDementiaCommunication DisordersCooperative StudyEatingHuman Old Age (65+)

Grant awards (26)

Strategies for the Treatment of Dysphagia in Patients with Alzheimer's Disease$223,135
R21 · FY2013 · AG · contact PI
Oropharyngeal Function After Radiotherapy with IMRT$428,419
R01 · FY2010 · DC · contact PI
Oropharyngeal Function After Radiotherapy with IMRT$548,710
R01 · FY2009 · DC · contact PI
Oropharyngeal Function After Radiotherapy with IMRT$534,193
R01 · FY2008 · DC · contact PI
Oropharyngeal Function After Radiotherapy with IMRT$493,020
R01 · FY2007 · DC · contact PI
Oropharyngeal Function After Radiotherapy with IMRT$494,171
R01 · FY2006 · DC · contact PI
Effects of Swallowing Therapy in Head and Neck Cancer$447,201
R01 · FY2006 · CA · contact PI
Effects of Swallowing Therapy in Head and Neck Cancer$757,124
R01 · FY2005 · CA
Effects of Swallowing Therapy in Head and Neck Cancer$745,066
R01 · FY2004 · CA
ASHA CLINICAL TRIALS COOPERATIVE GROUPS$350,135
U01 · FY2004 · DC
ASHA CLINICAL TRIALS COOPERATIVE GROUPS$862,510
U01 · FY2003 · DC
Effects of Swallowing Therapy in Head and Neck Cancer$725,450
R01 · FY2003 · CA
Effects of LSVT on Dysphagia in Parkinson's Disease$144,453
R21 · FY2003 · DC
ASHA CLINICAL TRIALS COOPERATIVE GROUPS$880,245
U01 · FY2002 · DC
Effects of Swallowing Therapy in Head and Neck Cancer$530,555
R01 · FY2002 · CA
Effects of LSVT on Dysphagia in Parkinson's Disease$136,943
R21 · FY2002 · DC
ASHA CLINICAL TRIALS COOPERATIVE GROUPS$937,689
U01 · FY2001 · DC
REHABILITATION OF ORAL CANCER PATIENTS AND BEHAVIOR MODIFICATION$103,677
P50 · FY2001 · DE
REHABILITATION OF ORAL CANCER PATIENTS AND BEHAVIOR MODIFICATION$103,677
P50 · FY2001 · DE
CCSP IN HEAD AND NECK CANCER REHABILITATION$1,478,819
P01 · FY2000 · CA
ASHA CLINICAL TRIALS COOPERATIVE GROUPS$1,239,953
U01 · FY2000 · DC
LONG-TERM SURVIVORS OF HEAD AND NECK CANCER$254,092
P01 · FY2000 · CA
BIOMECHANICS OF SWALLOW AND SENSORY INPUT AFTER HEAD AND NECK CANCER$254,092
P01 · FY2000 · CA
CORE--DATA REDUCTION, ANALYSIS, AND STORAGE$254,092
P01 · FY2000 · CA
REHABILITATION OF ORAL CANCER PATIENTS AND BEHAVIOR MODIFICATION$112,804
P50 · FY2000 · DE
REHABILITATION OF ORAL CANCER PATIENTS AND BEHAVIOR MODIFICATION$108,472
P50 · FY2000 · DE